Journal profile · Medicine-Oncology
Frontiers in Hematology
ISSN 2813-3935 · Frontiers Media S.A. · Switzerland
Frontiers in Hematology: impact factor 1.2 (journal website); fully open access; APC charged, amount not published; review about 15 weeks (community reports); 54 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Frontiers in Hematology is published by Frontiers Media S.A.. By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, Hemoglobinopathies and Related Disorders and Hematopoietic Stem Cell Transplantation, together about 27.6% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Hematology is a multidisciplinary platform dedicated to the dissemination of high-quality scientific articles in hematology, bringing together experts to inspire and promote cutting-edge research. Led by Field Chief Editor Hans Hasselbalch (University of Copenhagen, Denmark), Frontiers in Hematology seeks to advance our knowledge of all the factors that determine the presence or absence of hematological diseases and disorders. Frontiers in Hematology welcomes contributions in the various domains of hematological research, from basic to clinical studies. Topics of interest include: blood cancer hematopoiesis and stem cells immunobiology and immunotherapy red cells, iron and erythropoiesis. Articles that advance the UN’s Sustainable Development Goals (SDGs), especially SDG 3: good health and wellbeing, are particularly welcome. Frontiers in Hematology aims to be at the forefront of disseminating and communicating scientific advancements and impactful discoveries in the field of hematology to researchers, academics, clinicians, and the public worldwide.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editorial board by country: none in mainland China; most named United States 6, United Kingdom 3, Japan 1, India 1, France 1 (15 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myeloid Leukemia ResearchMedicine11.1%
- Hemoglobinopathies and Related DisordersMedicine9.5%
- Hematopoietic Stem Cell TransplantationMedicine7%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine6.1%
- CAR-T cell therapy researchMedicine5.9%
- Multiple Myeloma Research and TreatmentsMedicine5.3%
- Lymphoma Diagnosis and TreatmentMedicine5%
- Blood groups and transfusionMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.2Publisher website ·
- CiteScore 2026-06
- 1.2LetPub ·
- CiteScore (publisher)
- 1.2Publisher website ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.31LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 13OpenAlex ·
- 2-year mean citedness
- 2.1OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 50LetPub ·
Articles by year OpenAlex count · 202 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 42 | 42 | 8 |
| 2025 | 54 | 54 | 65 |
| 2024 | 61 | 61 | 256 |
| 2023 | 34 | 34 | 148 |
| 2022 | 11 | 11 | 23 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,950 | Yes | CC BY | |
| OpenAlex | CHF 1,950 | — | — | |
| LetPub | USD 2,080 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
APCs apply to articles accepted for publication by external editors following rigorous peer review. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Peer review process described as rigorous and transparent, combining expert review and constructive dialogue. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2813-3935
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Hematology
What is the impact factor of Frontiers in Hematology?
The journal's website gives an impact factor of 1.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.2, h-index 12.
How long does peer review take at Frontiers in Hematology?
Authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Hematology?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Hematology based?
Of the 15 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (6), United Kingdom (3) and Japan (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Hematology?
According to LetPub and DOAJ records, Frontiers in Hematology is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science; that list has not been checked against each database.
Is Frontiers in Hematology open access, and what is the APC?
Frontiers in Hematology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .